ArticleOncogene2018

Novel bone morphogenetic protein receptor inhibitor JL5 suppresses tumor cell survival signaling and induces regression of human lung cancer.

Jenna H Newman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.